Cargando…

Herpes Virus MicroRNA Expression and Significance in Serous Ovarian Cancer

Serous ovarian cancer (SEOC) is the deadliest gynecologic malignancy. MicroRNAs (miRNAs) are a class of small noncoding RNAs which regulate gene expression and protein translation. MiRNAs are also encoded by viruses with the intent of regulating their own genes and those of the infected cells. This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandya, Deep, Mariani, Marisa, McHugh, Mark, Andreoli, Mirko, Sieber, Steven, He, Shiquan, Dowell-Martino, Candice, Fiedler, Paul, Scambia, Giovanni, Ferlini, Cristiano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259392/ https://www.ncbi.nlm.nih.gov/pubmed/25485872 http://dx.doi.org/10.1371/journal.pone.0114750

Ejemplares similares

Epstein-Barr Virus MicroRNA Expression Increases Aggressiveness of Solid Malignancies
por: Pandya, Deep, et al.
Publicado: (2015)

Integrated Multidimensional Analysis Is Required for Accurate Prognostic Biomarkers in Colorectal Cancer
por: Mariani, Marisa, et al.
Publicado: (2014)

HGF/c-Met axis drives cancer aggressiveness in the neo-adjuvant setting of ovarian cancer
por: Mariani, Marisa, et al.
Publicado: (2014)

Adrenomedullin in Ovarian Cancer: Foe In Vitro and Friend In Vivo?
por: Baranello, Cinzia, et al.
Publicado: (2012)

MiR-200c and HuR in ovarian cancer
por: Prislei, Silvia, et al.
Publicado: (2013)

Free Testosterone Drives Cancer Aggressiveness: Evidence from US Population Studies
por: Shahabi, Shohreh, et al.
Publicado: (2013)

Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer
por: Prislei, Silvia, et al.
Publicado: (2015)

Defining “mutation” and “polymorphism” in the era of personal genomics
por: Karki, Roshan, et al.
Publicado: (2015)

Identification of the First Inhibitor of the GBP1:PIM1 Interaction. Implications for the Development of a New Class of Anticancer Agents against Paclitaxel Resistant Cancer Cells
por: Andreoli, Mirko, et al.
Publicado: (2014)

The significance of the alteration of 8-OHdG in serous ovarian carcinoma
por: Xu, Xia, et al.
Publicado: (2013)

Exploring the Control of PARP1 Levels in High-Grade Serous Ovarian Cancer
por: Raspaglio, Giuseppina, et al.
Publicado: (2023)

Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2018)

Significance of TEAD Family in Diagnosis, Prognosis and Immune Response for Ovarian Serous Carcinoma
por: Ren, Xinxin, et al.
Publicado: (2021)

Prognostic significance of intra-tumoral budding in high-grade serous ovarian carcinomas
por: Hachisuga, Toru, et al.
Publicado: (2022)

Prognostic Significance of HE4 Tissue Expression in Serous Epithelial Ovarian Carcinoma
por: Sethi, Ankita, et al.
Publicado: (2022)

Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment
por: Ciucci, Alessandra, et al.
Publicado: (2016)

Clinical Value of lncRNA MEG3 in High-Grade Serous Ovarian Cancer
por: Buttarelli, Marianna, et al.
Publicado: (2020)

NLR and BRCA mutational status in patients with high grade serous advanced ovarian cancer
por: Marchetti, Claudia, et al.
Publicado: (2021)

Expression of Yes-associated protein 1 and its clinical significance in ovarian serous cystadenocarcinoma
por: Cho, Sang Yeon, et al.
Publicado: (2017)

Assessment of Significant Pathway Signaling and Prognostic Value of GNG11 in Ovarian Serous Cystadenocarcinoma
por: Jiang, Ming-Min, et al.
Publicado: (2021)

Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine
por: Nero, Camilla, et al.
Publicado: (2021)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas
por: Cheon, Dong‐Joo, et al.
Publicado: (2014)

Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers
por: Ciucci, Alessandra, et al.
Publicado: (2016)

Expression and Clinical Significance of the NCAPH, AGGF1, and FOXC2 Proteins in Serous Ovarian Cancer
por: Sun, Yingying, et al.
Publicado: (2021)

Bioinformatic Analysis for Influential Core Gene Identification and Prognostic Significance in Advanced Serous Ovarian Carcinoma
por: Song, Changho, et al.
Publicado: (2021)

Clinical significance of metabolism-related genes and FAK activity in ovarian high-grade serous carcinoma
por: Sato, Masakazu, et al.
Publicado: (2022)

Clinical significance of SPOCK2 expression signature for high-grade serous ovarian cancer patients
por: Jiao, Mi, et al.
Publicado: (2022)

T-Cell Receptor Repertoire Characteristics Associated with Prognostic Significance in High-Grade Serous Ovarian Carcinoma
por: Kim, Ju-Won, et al.
Publicado: (2023)

KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer
por: De Donato, Marta, et al.
Publicado: (2020)

MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors
por: Yu, Xin-ping, et al.
Publicado: (2021)

Pathological Chemotherapy Response Score in Patients Affected by High Grade Serous Ovarian Carcinoma: The Prognostic Role of Omental and Ovarian Residual Disease
por: Santoro, Angela, et al.
Publicado: (2019)

Notch signaling in serous ovarian cancer
por: Groeneweg, Jolijn W, et al.
Publicado: (2014)

Gastric metastasis of ovarian serous cystadenocarcinoma
por: Yang, Shiqiang
Publicado: (2018)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

A rare case of ovarian adenomyoma mimicking primary invasive ovarian cancer with a contralateral serous borderline ovarian tumor: A case report and review of the literature
por: Liberale, Viola, et al.
Publicado: (2020)

Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma
por: Dobrzycka, Bozena, et al.
Publicado: (2015)

Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian Cancer
por: Svoboda, Martin, et al.
Publicado: (2018)

Objective, domain-specific HER2 measurement in uterine and ovarian serous carcinomas and its clinical significance
por: Carvajal-Hausdorf, Daniel E., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pqt547ohij8qk3e06nb3qr9aua